Cargando…

Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis

OBJECTIVES: The aim of this study was to compare the clinical effectiveness of tofacitinib and abatacept and clarify the impact of the HLA-DRB1 shared epitope (SE) on responses to these treatments in patients with rheumatoid arthritis (RA). METHODS: After adjustments by propensity score matching, 70...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirose, Wataru, Harigai, Masayoshi, Amano, Koichi, Hidaka, Toshihiko, Itoh, Kenji, Aoki, Kazutoshi, Nakashima, Masahiro, Nagasawa, Hayato, Komano, Yukiko, Nanki, Toshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407060/ https://www.ncbi.nlm.nih.gov/pubmed/34465391 http://dx.doi.org/10.1186/s13075-021-02612-w

Ejemplares similares

Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
por: Hirose, Wataru, et al.
Publicado: (2022)

Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study
por: Muraoka, Sei, et al.
Publicado: (2021)

Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
por: Yokoyama-Kokuryo, Waka, et al.
Publicado: (2020)

Diagnostic performance of measuring antibodies to the glycopeptidolipid core antigen specific to Mycobacterium avium complex in patients with rheumatoid arthritis: results from a cross-sectional observational study
por: Hirose, Wataru, et al.
Publicado: (2015)

Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis
por: Inoue, Mariko, et al.
Publicado: (2023)

Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts
por: Komano, Yukiko, et al.
Publicado: (2006)

Genetic dissection of HLA-DRB1*15:01 and XL9 region variants in Japanese patients with systemic lupus erythematosus: primary role for HLA-DRB1*15:01
por: Kawasaki, Aya, et al.
Publicado: (2023)

Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
por: Harrold, Leslie R., et al.
Publicado: (2023)

HLA DRB101 and macrophagic myofasciitis
por: Guis, S, et al.
Publicado: (2003)

Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study
por: Kawasaki, Aya, et al.
Publicado: (2016)

Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
por: Ouedraogo, Alfred Rakissida, et al.
Publicado: (2023)

Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis
por: Harigai, Masayoshi, et al.
Publicado: (2016)

Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
por: Michou, Laëtitia, et al.
Publicado: (2006)

PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis
por: Hisa, Kaori, et al.
Publicado: (2017)

Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires
por: Scholz, Erika Margaret, et al.
Publicado: (2017)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor
por: Kubota, Tetsuo, et al.
Publicado: (2007)

HLA-DRB1 genes and extraarticular rheumatoid arthritis
por: Roudier, Jean
Publicado: (2006)

Association of the HLA-DRB1 with Scleroderma in Chinese Population
por: He, Dongyi, et al.
Publicado: (2014)

Identification of HLA-DRB1 association to adalimumab immunogenicity
por: Liu, Mohan, et al.
Publicado: (2018)

HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
por: Hoffmann, Steve, et al.
Publicado: (2008)

Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis
por: Nanki, Toshihiro, et al.
Publicado: (2009)

HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA- DRB1*0301 (DR3) gene
Publicado: (1996)

HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
por: Brynedal, Boel, et al.
Publicado: (2007)

Association of HLA-DRB1*15 and HLA-DQB1* 06 with SLE in Saudis
por: Al-Motwee, Saleh, et al.
Publicado: (2013)

Association between migraine and HLA–DRB1 gene polymorphisms
por: Rainero, I., et al.
Publicado: (2005)

Clustering and Alignment of Polymorphic Sequences for HLA-DRB1 Genotyping
por: Ringquist, Steven, et al.
Publicado: (2013)

Association of HLA DRB variants to genetic predisposition to rheumatoid arthritis
por: Jarullah, Bushra S
Publicado: (2014)

Diversity of Extended HLA-DRB1 Haplotypes in the Finnish Population
por: Wennerström, Annika, et al.
Publicado: (2013)

The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases
por: Bettencourt, Andreia, et al.
Publicado: (2015)

Hypomethylation of HLA-DRB1 and its clinical significance in psoriasis
por: Zong, Wenkai, et al.
Publicado: (2016)

HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA
por: Rigby, William, et al.
Publicado: (2021)

Evidence for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the impact of DRB1*09 on disease onset in a Chinese Han population
por: Zhang, Furen, et al.
Publicado: (2009)

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes
por: Zhao, Lue Ping, et al.
Publicado: (2016)

The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression
por: Habets, Thomas H. P. M., et al.
Publicado: (2018)

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
por: Fukuda, Shin, et al.
Publicado: (2014)

Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) in Patients with Multiple Sclerosis in Khuzestan Province
por: DELFAN, Nooshin, et al.
Publicado: (2021)

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
por: Sakai, Ryoko, et al.
Publicado: (2015)

Influence of the physicochemical properties of the HLA-DRB1 shared epitope negative alleles on rheumatoid arthritis susceptibility
por: Michou, L, et al.
Publicado: (2004)

Modeling of PTPN22 and HLA-DRB1 susceptibility to rheumatoid arthritis
por: Gagnon, France, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_vdeg3qo6n9lat5sfqivbetl6g2